HSBC Holdings plc is assessing options for its Singapore insurance operations, including a potential sale of HSBC Life (Singapore), according to people familiar with the matter, in a move that could alter its insurance footprint in the city-state.
The review, being undertaken with a financial adviser, could value the business at more than US$1 billion (S$1.29 billion), the people said, as reported by The Straits Times. Potential bidders are understood to include regional and global insurers as well as investment firms, although interest is still at an early stage and may not result in a transaction. The discussions follow earlier disposals and exits in other markets under group chief executive Georges Elhedery. The process remains preliminary and HSBC has not made a final decision on whether to proceed with a sale of the Singapore unit, the people said.
HSBC Life (Singapore) offers protection and savings products, including life and critical illness cover, personal accident, health, and savings plans. The entity operates alongside HSBC’s retail and wealth businesses in Singapore, with distribution through branches, relationship managers, and digital channels. According to The Straits Times, a spokesperson for HSBC declined to comment on market speculation about a possible sale. The spokesperson said the group remains committed to Singapore as an international wealth and wholesale banking hub and that the market is important to HSBC’s strategy, with continued investment in its local operations.
HSBC has expanded its insurance presence in Singapore over the past decade through both organic growth and acquisitions. In 2022, the bank acquired AXA Insurance Singapore for US$529 million, increasing its life and general insurance activities and broadening its reach in the domestic market. Any transaction involving HSBC Life (Singapore) would affect bancassurance arrangements, product manufacturing responsibilities, and internal capital allocation. For a buyer, the business would provide an existing in-force portfolio, access to HSBC’s customer base in Singapore, and a licensed platform in a developed insurance market. For HSBC, a sale or partnership could release capital and change the way insurance products are supplied to its customers, depending on the eventual structure.
A potential deal would add to a series of insurance transactions in Southeast Asia, where multinational and regional groups have been reshaping their portfolios, reconsidering ownership levels, and using acquisitions to adjust their regional presence. Recent activity includes Chubb’s acquisition of Liberty Mutual’s operations in Thailand and Vietnam, and Sumitomo Life Insurance’s purchase of Singapore Life Holdings (Singlife) in 2024. Other groups, such as FWD Group Holdings, have pursued transactions and partnerships to expand in life and health lines in the region.
Not all proposed deals have gone ahead. Allianz withdrew an offer in late 2024 to acquire a majority stake in Singapore’s Income Insurance, halting one of the larger potential transactions in the local market amid regulatory, valuation, and partner-related considerations. For insurance professionals, a possible sale of HSBC Life (Singapore) is relevant because it links banking, wealth management, and insurance in a single platform. Market participants are likely to focus on how any buyer would handle in-force portfolios, renewal rights, bancassurance channels, and integration with existing operations, as well as whether other bank-owned insurers in Asia might review their positions in response.
The review of the Singapore insurance unit follows HSBC’s third-quarter 2025 (3Q25) results, in which Elhedery highlighted efforts to reduce complexity and prioritise areas where the bank sees stronger returns. “We are becoming a simple, more agile, focused bank, built on our core strengths. The intent with which we are executing our strategy is reflected in our performance this quarter, despite taking legal provisions related to historical matters. The positive progress we are making gives us confidence in our ability to upgrade our targets, and we now expect 2025 RoTE excluding notable items to be mid-teens, or better. We remain fully focused on helping our customers navigate new economic realities, putting their changing needs at the heart of everything we do,” Elhedery said in the earnings release.
In the third quarter of 2025, HSBC reported profit before tax of US$7.3 billion, down US$1.2 billion from a year earlier, mainly due to higher operating expenses that included US$1.4 billion of legal provisions. On a constant-currency basis and excluding notable items, profit before tax rose 3% to US$9.1 billion, driven by revenue growth in wealth and higher banking net interest income. Annualised return on average tangible equity declined to 12.3% from 15.5% in the prior-year quarter, but on an adjusted basis excluding notable items it increased to 16.4%. Group revenue rose 5% year on year to US$17.8 billion. Net interest income increased 15% to US$8.8 billion, and net interest margin widened to 1.57%.
For insurers, reinsurers, and investors in Asia, HSBC’s review of its Singapore life arm illustrates ongoing changes in ownership structures and distribution strategies in the region. The eventual outcome – whether a full sale, a partial stake sale, a long-term partnership, or retention of the business – is likely to influence how banks and insurers approach bancassurance, capital deployment, and product manufacturing in markets targeted for wealth and protection business.
Potential bidders would be expected to examine the quality of the in-force book, new business economics, regulatory capital needs, and the duration and terms of any distribution arrangements with HSBC. At the same time, industry participants will be watching whether HSBC seeks to preserve long-term access to insurance offerings for its Singapore customers through distribution agreements or joint ventures, even if it reduces or ends direct ownership of the underlying insurance entity.
